MACKENZIE ANDRASIK: Open Payments
NPI 1992402291 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 8 payments from 6 companies in 2025. Trend: 2023 $932 · 2024 $824 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $179 |
| Regeneron Healthcare Solutions, Inc. | 1 | $116 |
| E.R. Squibb & Sons, L.L.C. | 1 | $114 |
| Novartis Pharmaceuticals Corporation | 2 | $105 |
| UCB, Inc. | 1 | $91 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $72 |
Products named: Sotyktu, DUPIXENT, Bimzelx, COSENTYX.
Industry payments across OH — which companies pay providers there.
